Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is not yet recruiting. It focuses on schizophrenia and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in the United Kingdom.
In ManchesterThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in Global.
In Global
This study is not yet recruiting in Global. It is testing carliprazine and Aripiprazole for schizophrenia.
In GlobalThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in Global.
In GlobalThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in the United States.
In New YorkThis study is not yet recruiting in China. It focuses on Schizophrenia.
In ShanghaiThis study is not yet recruiting in China. It is testing LY03020 for schizophrenia.
In BeijingThis study is not yet recruiting in Global. It focuses on Schizophrenia.
In GlobalThis study is not yet recruiting. It focuses on schizophrenia and currently lists study information in Global.
In GlobalThis study is not yet recruiting in Global. It focuses on Schizophrenia.
In GlobalThis study is not yet recruiting in Belgium, in Austria, in Czech Republic, .... It focuses on schizophrenia.
Multiple locations, including InnsbruckHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.